# Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain

> **NCT07396129** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 30 (estimated)

## Conditions studied

- Neuropathic Chronic Pain

## Interventions

- **DRUG:** Lidocaine (23%) + Tetracaine (7%)
- **DRUG:** Placebo cream application

## Key facts

- **NCT ID:** NCT07396129
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-23
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396129, "Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07396129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*